Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAMOVID trial of camostat mesylate in ambulatory adult COVID-19 patients
2020-003366-39Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of camostat mesilate in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Hospitalization due to COVID-19 deterioration. Started Jul 2020; status: active.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-003366-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003366-39.